Catalyst Wire Dossier Catalyst Wire Dossier

rhPro-UK

recombinant human pro-urokinase · Tasly Biopharmaceuticals Co., Ltd.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for rhPro-UK, covering 2020-04-28 to 2026-02-05. Get the full timeline:

Most recent: Clinical Trial Update: Intravenous rhPro-UK Before Stroke Thrombectomy in the Extended Time Window (BRIDGE-PUK EXTEND) [Phase 3]

See pricing